Peterseim D S, Pappas T N, Meyers C H, Shaeffer G S, Meyers W C, Van Trigt P
Department of General and Thoracic Surgery, Duke University Medical Center, Durham, N.C. 27710, USA.
J Heart Lung Transplant. 1995 Jul-Aug;14(4):623-31.
Immunosuppression increases the risk of biliary complications in heart transplant recipients.
Patients undergoing heart transplantation since 1986 who were at risk for cholelithiasis (n = 60) were retrospectively studied.
Cholestatic jaundice developed in all patients after the operation because of biliary obstruction from cholelithiasis, cyclosporine toxicity, Imuran toxicity, or Gilbert's disease. The incidence of cholelithiasis or sludge was 42% (n = 25 of 60). Gallstones developed within 1.8 +/- 1.1 years in 17% of patients (n = 8 of 48) with a normal pretransplantation ultrasonogram. Biliary colic or gallstone pancreatitis developed 2 +/- 1.2 years after transplantation in 58% of patients (n = 7 of 12) with asymptomatic gallstones diagnosed before transplantation. The overall incidence of cholecystectomy or cholecystectomy with Roux-en-Y cystojejunostomy was 40% (n = 24). Both open cholecystectomy (n = 5) and laparoscopic cholecystectomy (n = 19) were performed without significant complications. Recovery is significantly more rapid (p < 0.05) after laparoscopic cholecystectomy versus open cholecystectomy (1 week versus 3 weeks).
This analysis indicates that transplant candidates who have gallstones on pretransplantation evaluation or in whom gallstones develop after transplantation should undergo laparoscopic cholecystectomy at the earliest time in their posttransplantation course (i.e., 3 months) regardless of their symptomatic status. Removal of the diseased gallbladder not only simplifies the evaluation of cholestatic jaundice by eliminating the need for multiple ultrasonograms to exclude acute cholecystitis or choledocholithiasis but also safely minimizes the risk of the development of severe biliary complications.
免疫抑制会增加心脏移植受者发生胆道并发症的风险。
对自1986年以来接受心脏移植且有患胆结石风险的患者(n = 60)进行回顾性研究。
所有患者术后均因胆结石、环孢素毒性、硫唑嘌呤毒性或吉尔伯特病导致的胆道梗阻而出现胆汁淤积性黄疸。胆结石或胆泥的发生率为42%(60例中的25例)。移植前超声检查正常的患者中,17%(48例中的8例)在1.8±1.1年内出现胆结石。移植前诊断为无症状胆结石的患者中,58%(12例中的7例)在移植后2±1.2年出现胆绞痛或胆结石性胰腺炎。胆囊切除术或胆囊切除术加Roux-en-Y式囊肿空肠吻合术的总体发生率为40%(24例)。开腹胆囊切除术(5例)和腹腔镜胆囊切除术(19例)均未发生严重并发症。与开腹胆囊切除术相比,腹腔镜胆囊切除术后恢复明显更快(p < 0.05)(1周对3周)。
该分析表明,移植前评估发现有胆结石或移植后出现胆结石的移植候选者,无论其症状状态如何,均应在移植后尽早(即3个月)接受腹腔镜胆囊切除术。切除患病胆囊不仅通过无需多次超声检查排除急性胆囊炎或胆总管结石而简化了胆汁淤积性黄疸的评估,还安全地降低了发生严重胆道并发症的风险。